United States - English - NLM (National Library of Medicine)

dr.reddy's laboratories limited - meprobamate (unii: 9i7lny769q) (meprobamate - unii:9i7lny769q) - meprobamate 200 mg - meprobamate tablets are indicated for the management of anxietydisorders or for the short-term relief of the symptoms of anxiety.anxiety or tension associated with the stress of everyday life usuallydo not require treatment with an anxiolytic. the effectiveness of meprobamate tablets in long-term use, that is,more than 4 months, has not been assessed by systematic clinicalstudies. the physician should periodically reassess the usefulness ofthe drug for the individual patient. acute intermittent porphyria as well as allergic or idiosyncraticreactions to meprobamate or related compounds such ascarisoprodol, mebutamate, tybamate, or carbromal.

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - meprobamate (unii: 9i7lny769q) (meprobamate - unii:9i7lny769q) - meprobamate 200 mg - meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic. the effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the individual patient. acute intermittent porphyria as well as allergic or idiosyncratic reactions to meprobamate or related compounds such as carisoprodol, mebutamate, tybamate, or carbromal.

United States - English - NLM (National Library of Medicine)

taro pharmaceutical industries ltd. - meprobamate (unii: 9i7lny769q) (meprobamate - unii:9i7lny769q) - meprobamate 200 mg - meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic. the effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the individual patient. acute intermittent porphyria as well as allergic or idiosyncratic reactions to meprobamate or related compounds such as carisoprodol, mebutamate, tybamate, or carbromal.

United States - English - NLM (National Library of Medicine)

alembic pharmaceuticals limited - meprobamate (unii: 9i7lny769q) (meprobamate - unii:9i7lny769q) - meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic. the effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the individual patient.  acute intermittent porphyria as well as allergic or idiosyncratic reactions to meprobamate or related compounds such as carisoprodol, mebutamate, tybamate, or carbromal.

United States - English - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - meprobamate (unii: 9i7lny769q) (meprobamate - unii:9i7lny769q) - meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic. the effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the individual patient.  acute intermittent porphyria as well as allergic or idiosyncratic reactions to meprobamate or related compounds such as carisoprodol, mebutamate, tybamate, or carbromal.

United States - English - NLM (National Library of Medicine)

cipla usa inc. - meprobamate (unii: 9i7lny769q) (meprobamate - unii:9i7lny769q) - meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic. the effectiveness of meprobamate tablets in long-term use, that is,more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the individual patient. acute intermittent porphyria as well as allergic or idiosyncratic reactions to meprobamate or related compounds such as carisoprodol, mebutamate, tybamate, or carbromal.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

akromed -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

akromed -

United States - English - NLM (National Library of Medicine)

mikart, inc. - meprobamate (unii: 9i7lny769q) (meprobamate - unii:9i7lny769q), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - tablet - 200 mg - as an adjunct in the short-term treatment of pain accompanied by tension and/or anxiety in patients with musculoskeletal disease. clinical trials have demonstrated that in these situations relief of pain is somewhat greater than with aspirin alone.  equagesic is not intended for use longer than 10 days. usage in pregnancy and lactation an increased risk of congenital malformations associated with the use of minor tranquilizers (meprobamate, chlordiazepoxide, and diazepam) during the first trimester of pregnancy has been suggested in several studies. because use of these drugs is rarely a matter of urgency, their use during this period should almost always be avoided. because of the known effect of non-steroidal anti-inflammatory drugs (nsaids) on the fetal cardiovascular system (closure of the ductus arteriosus), use during the third trimester of pregnancy should be avoided. salicylate products have also been associated with alterations in maternal and neonatal hemostasis mechanisms, decreased birth weight, a

United States - English - NLM (National Library of Medicine)

watson laboratories, inc. - meprobamate (unii: 9i7lny769q) (meprobamate - unii:9i7lny769q) - meprobamate 200 mg